Research Grants 6 show all


$171.5K
2008

$570.2K
2010

$599.9K
2012

$224.9K
2014

Patents 80show all

  • 61
    C12N - Microorganisms or enzymes
  • 53
    A61K - Preparations for medical, dental, or toilet purposes
  • 13
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 9
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 1
    Y02A - Technologies for adaptation to climate change

Clinical Trials 2show all

1Phase 11Phase 1/Phase 2

SEC Filings show all


65
8-K

14
10-Q

5
10-K

4
D

1
S-1

Contact Information

Austin, TX
United States

SEC Form D Funding Events

DateOfferedSoldType
2015-05-01$45,000,000$41,789,527Equity
2012-11-02$34,499,990$17,249,995Equity
2011-08-23$1,500,000$1,500,000Equity

Key Executives

  • Paul Lammers
    Executive Officer, Director
  • Matthew M Winkler
    Director
  • Christopher D Earl
    Director
  • Evan S Melrose
    Director
  • Corey S Goodman
    Director
  • Lynne Hohlfeld
    Executive Officer
  • Ana C Ward
    Executive Officer
  • Michael Powell
    Director
  • Elaine V Jones
    Director
  • Edward Mathers
    Director
  • Corey Goodman
    Director
  • Ana Ward
    Executive Officer
  • Jon Irvin
    Executive Officer
  • Sinil Kim
    Executive Officer
  • Casi DeYoung
    Executive Officer
  • Matthew Winkler
    Director
  • Clay Siegall
    Director
  • Larry Alleva
    Director
  • Elaine Jones
    Director
  • Ed Mathers
    Director